Microarray Market Industry Size, Growth, Analysis, Trends and Forecast 2025

The testing and research of a large number of genes cannot be achieved by using traditional methods. Hence, the microarray is one of the technologies that are used by researchers to overcome the limitation of traditional tools. Using microarrays, the researchers can analyze the expression of many genes simultaneously and efficiently. Microarrays are used in various application such as gene discovery, diseases diagnosis, drug discovery, toxicological research and so on. The widespread global adoption of personalized medication and the need for the error-free molecular testing tool are the factor that is boosting the growth of the microarray market globally. The increasing prevalence of chronic diseases leads to the demand for an innovative molecular testing solution to perform the microbiology, cancer, and pharmacogenetic testing. Moreover, the usage of microarrays in bacterial pathogenesis research is also fuelling the microarray market growth.

Get Sample Copy of Microarray Market at: https://www.omrglobal.com/request-sample/microarray-market

There are various companies involved in the microarray technology such as Abcam PLC, Agilent Technologies Inc., Applied Microarrays, Inc., CDI Laboratories, Inc., GE Healthcare, PerkinElmer, Inc., RayBiotech, Inc. And so on.

Although, the lack of funding for microarray development and the cost of preparing microarrays are the major restraining factor for this market. The availability of some microarrays such as Glycan is under threat due to the difficulty in procuring and distribution which can hinder the growth of the microarray market. Whereas, the emerging technologies for the diagnosis of microbial infections and the need for detection of chromosomal alteration also increase the demand for microarrays. Additionally, the increasing focus towards the function and recognition of glycan can be a huge opportunity for this market.

For More Information, get A full report of Microarray Market is available at: https://www.omrglobal.com/industry-reports/microarray-market

Geographically, the market is divided into North America, Europe, Asia-Pacific and Rest of the World. North America region is growing with significant growth and is dominating the global microarray market. The growth is attributed to the increasing prevalence of chronic diseases and extensive proteomics and genomics research. Europe is the second largest market due to the technological advancement in the biotechnology field. Asia-Pacific is considered as the growing market during the forecast period. The growing need for the molecular testing solution and high penetration of new technology are the key factors for the growth of the microarray market in Asia-Pacific region. The companies are focused on developing advanced microarray solutions to stay competitive in the market. Geographical expansion, merger & acquisition, finding a new market or innovate in their core competency in order to expand individual market share is a key strategy adopted by major market players.

Market Segmentation

Global Microarrays Market by Type

DNA Microarrays
Protein Microarray
Peptide Microarray
Tissue Microarray
Cellular Microarray
Others

Global Microarrays Market by Application

Diagnosis and Prognosis
Pharmacogenomics and Theragnostic
Drug Discovery
Other

For more customized data, request for report customization @ https://www.omrglobal.com/report-customization/microarray-market

Media Contact:

Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +1 646-755-7667, +91 7803040404

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

For More Information, Visit https://www.omrglobal.com/

This release was published on openPR.